Berberine and palmatine inhibit the growth of human rhabdomyosarcoma cells

References

• Meng FC, Wu ZF, Yin ZQ, et al. Coptidis rhizoma and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity. Chin Med. 2018;13:13.
   PubMed Web of Science ®Google Scholar
• Cheng YT, Yang CC, Shyur LF. Phytomedicine-modulating oxidative stress and the tumor microenvironment for cancer therapy. Pharmacol Res. 2016;114:128–143.
   PubMed Web of Science ®Google Scholar
• Mantena SK, Sharma SD, Katiyar SK. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther. 2006;5:296–308.
   PubMed Web of Science ®Google Scholar
• Yan K, Zhang C, Feng J, et al. Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells. Eur J Pharmacol. 2011;661:1–7.
   PubMed Web of Science ®Google Scholar
• James MA, Fu H, Liu Y, et al. Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis. Mol Carcinog. 2011;50:1–7.
   PubMed Web of Science ®Google Scholar
• Chidambara Murthy KN, Jayaprakasha GK, Patil BS. The natural alkaloid berberine targets multiple pathways to induce cell death in cultured human colon cancer cells. Eur J Pharmacol. 2012;688:14–21.
   PubMed Web of Science ®Google Scholar
• Ma C, Tang K, Liu Q, et al. Calmodulin as a potential target by which berberine induces cell cycle arrest in human hepatoma Bel7402 cells. Chem Biol Drug Des. 2013;81:775–783.
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu Q, Xu B, et al. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat Res. 2009;662:75–83.
   PubMed Web of Science ®Google Scholar
• Eo SH, Kim JH, Kim SJ. Induction of G2/M arrest by berberine via activation of PI3K/Akt and p38 in human chondrosarcoma cell line. Oncol Res. 2014;22:147–157.
   PubMed Web of Science ®Google Scholar
• Sun X, Guo W, Shen JK, et al. Rhabdomyosarcoma: advances in molecular and cellular biology. Sarcoma. 2015;2015:232010.
   PubMedGoogle Scholar
• Kikuchi K, Tsuchiya K, Otabe O, et al. Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcoma. Biochem Biophys Res Commun. 2008;365:568–574.
   PubMed Web of Science ®Google Scholar
• Jothi M, Nishijo K, Keller C, et al. AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell. Cell Cycle. 2012;11:895–908.
   PubMed Web of Science ®Google Scholar
• Rubin BP, Nishijo K, Chen HI, et al. Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell. 2011;16:177–191.
   Web of Science ®Google Scholar
• Yang L, Takimoto T, Fujimoto J. Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma. BMC Cancer. 2014;14:654.
   PubMed Web of Science ®Google Scholar
• Nishimura R, Takita J, Sato-Otsubo A, et al. Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array. Cancer Sci. 2013;104:856–864.
   PubMed Web of Science ®Google Scholar
• Sekiguchi M, Shiroko Y, Suzuki T, et al. Characterization of a human rhabdomyosarcoma cell strain in tissue culture. Biomed Phamacother. 1985;39:372–380.
   PubMed Web of Science ®Google Scholar
• McAllister RM, Melnyk J, Finkelstein JZ, et al. Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer. 1969;24:520–526.
   PubMed Web of Science ®Google Scholar
• Guo Y, Chen Y, Wei Y, et al. Label-free fluorescent aptasensor for potassium ion using structure-switching aptamers and berberine. Spectrochim Acta A Mol Biomol Spectrosc. 2015;136:1635–1641.
   PubMed Web of Science ®Google Scholar
• Mi R, Tu B, Bai XT, et al. Binding properties of palmatine to DNA: spectroscopic and molecular modeling investigations. Luminescence. 2015;30:1344–1351.
   PubMed Web of Science ®Google Scholar
• Lu J, Zhang Q, Tan D, et al. GABA A receptor π subunit promotes apoptosis of HTR-8/SVneo trophoblastic cells: implications in preeclampsia. Int J Mol Med. 2016;38:105–112.
   PubMed Web of Science ®Google Scholar
• Yosef R, Pilpel N, Tokarsky-Amiel R, et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun. 2016;7:11190.
   PubMed Web of Science ®Google Scholar
• Kumari S, Puneet, SB P, et al. Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer. Med Oncol. 2016;33:40.
   PubMed Web of Science ®Google Scholar
• Ueberberg S, Tannapfel A, Schenker P, et al. Differential expression of cell-cycle regulators in human beta-cells derived from insulinoma tissue. Metabolism. 2016;65:736–746.
   PubMed Web of Science ®Google Scholar
• Sharma V, Harafuji N, Belayew A, et al. DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS One. 2013;8:e64691.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang W, Kollman PA, et al. Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model. 2006;25:247–260.
   PubMed Web of Science ®Google Scholar
• Wang J, Wolf RM, Caldwell JW, et al. Development and testing of a general amber force field. J Comput Chem. 2004;25:1157–1174.
   PubMed Web of Science ®Google Scholar
• Wang J, Cieplak P, Kollman PA. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J Comput Chem. 2000;21:1049–1074.
   Web of Science ®Google Scholar
• Fukunishi F, Mikami Y, Nakamura H. Similarities among receptor pockets and among compounds: analysis and application to in silico ligand screening. J Mol Graph Model. 2005;24:34–45.
   PubMed Web of Science ®Google Scholar
• Hinson ARP, Jones R, Crose LES, et al. Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls. Front Oncol. 2013;3:183.
   PubMedGoogle Scholar
• Felix CA, Kappel CC, Mitsudomi T, et al. Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res. 1992;52:2243–2247.
   PubMed Web of Science ®Google Scholar
• Miyachi M, Kakazu N, Yagyu S, et al. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells. Clin Cancer Res. 2009;15:4077–4084.
   PubMed Web of Science ®Google Scholar
• Hambright HG, Batth IS, Xie J, et al. Palmatine inhibits growth and invasion in prostate cancer cell: potential role for rpS6/NFκB/FLIP. Mol Carcinog. 2015;54:1227–1234.
   PubMed Web of Science ®Google Scholar
• Rao PC, Begum S, Sahai M, et al. Coptisine-induced cell cycle arrest at G2/M phase and reactive oxygen species-dependent mitochondria-mediated apoptosis in non-small-cell lung cancer A549 cells. Tumor Biol. 2017;39:1010428317694565.
   Google Scholar
• Liu R, Cao Z, Pan Y, et al. Jatrorrhizine hydrochloride inhibits the proliferation and neovascularization of C8161 metastatic melanoma cells. Anticancer Drugs. 2013;24:667–676.
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete O. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.
   PubMed Web of Science ®Google Scholar
• Zhang X, Qiu F, Jiang J, et al. Intestinal absorption mechanisms of berberine, palmatine, jateorhizine, and coptisine: involvement of P-glycoprotein. Xenobiotica. 2011;41:290–296.
   PubMed Web of Science ®Google Scholar
• Bailon-Moscoso N, Cevallos-Solorzano G, Romero-Benavides JC, et al. Natural compounds as modulators of cell cycle arrest: application for anticancer chemotherapies. Curr Genomics. 2017;18:106–131.
   PubMed Web of Science ®Google Scholar
• He W, Wang B, Zhuang Y, et al. Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma QBC939 cells. J Pharmacol Sci. 2012;119:341–348.
   PubMed Web of Science ®Google Scholar
• Wang N, Wang X, Tan HY, et al. Berberine suppresses cyclin D1 expression through proteasomal degradation in human hepatoma cells. Int J Mol Sci. 2016;17:E1899.
   PubMed Web of Science ®Google Scholar
• Ke T, Deming X, Jian W, et al. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway. Toxicol Lett. 2016;240:68–80.
   PubMed Web of Science ®Google Scholar
• Shim JS, Lee J, Kim KN, et al. Development of a new Ca2+/calmodulin antagonist and its anti-proliferative activity against cololectal cancer cells. Biochem Biophys Res Commun. 2007;359:747–751.
   PubMed Web of Science ®Google Scholar
• Ruan H, Zhan YY, Hou J, et al. Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells. Oncogene. 2017;36:6906–6918.
   PubMed Web of Science ®Google Scholar
• Li M, Nagamori E, Kino-oka M. Disruption of myoblast alignment by highly motile rhabdomyosarcoma cell in tissue structure. J Biosci Bioeng. 2017;123:259–264.
   PubMed Web of Science ®Google Scholar
• Moghadam AR, Da Silva Rosa SC, Samiei E, et al. Autophagy modulates temozolomide-induced cell death in alveolar rhabdomyosarcoma cells. Cell Death Discov. 2018;4:52.
   PubMed Web of Science ®Google Scholar
• He J, Xiong L, Li Q, et al. 3D modeling of cancer stem cell niche. Oncotarget. 2018;9:1326–1345.
   PubMedGoogle Scholar
• Chakravarthy D, Munoz AR, Su A, et al. Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1. Cancer Lett. 2018;419:103–115.
   PubMed Web of Science ®Google Scholar